Related Experiment Video
Updated: May 2, 2026

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
Published on: May 23, 2025
Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients
1Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, P.O. Box 301402, Unit #431, Houston, TX, 77232-1402, USA, emle@mdanderson.org.
Abstract:
Posterior reversible encephalopathy syndrome is a well-recognized entity associated with a variety of benign and malignant conditions. This syndrome typically manifests itself with headache, visual loss, and seizures. Radiographic abnormalities consist of white matter edema involving the posterior parietal and occipital lobes, manifested as increased T2 and fluid-attenuated inversion recovery signal intensity on magnetic resonance imaging. In the last decade, there has been a reported increase in the incidence of posterior reversible encephalopathy syndrome in cancer patients. The diagnosis can be challenging in this patient population. Early recognition and initiation of appropriate therapy with removal of the causative agent is essential in order to prevent permanent neurologic sequelae.
Related Concept Videos
Hepatic Encephalopathy
Encephalitis l: Introduction
Cerebral Edema ll: Pathophysiology
Encephalitis ll: Pathophysiology
Cytotoxic Edema: Pathophysiology
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

